ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,477.90
0.16%
Dow Jones
39,127.80
0.04%
US Dollar vs MXN
18.30425
-0.06%
Brent Oil
84.365
-0.12%
Bitcoin
60,630.50
-0.29%
Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Interpace Biosciences Inc (IDXG)

  7. Interpace Biosciences Inc (IDXG) Noticias

IDXG

Interpace Biosciences (IDXG)

Interpace Biosciences Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:IDXG
FechaHoraFuenteTítuloSímboloCompañía
12/05/202315:35Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:IDXGInterpace Biosciences Inc
12/05/202315:24Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:IDXGInterpace Biosciences Inc
03/05/202314:17Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:IDXGInterpace Biosciences Inc
28/04/202315:20Edgar (US Regulatory)Amended Annual Report (10-k/a)NASDAQ:IDXGInterpace Biosciences Inc
27/03/202315:40Edgar (US Regulatory)Annual Report (10-k)NASDAQ:IDXGInterpace Biosciences Inc
14/11/202215:41GlobeNewswire Inc.Interpace Biosciences Announces Third Quarter 2022 Financial and Business Results Sale of Pharma Significantly Improves Liquidity Resulting in Removal of Going ConcernNASDAQ:IDXGInterpace Biosciences Inc
20/10/202215:28GlobeNewswire Inc.Interpace Biosciences Announces New Real-world Data; Presented at the American Thyroid Association 2022 Annual MeetingNASDAQ:IDXGInterpace Biosciences Inc
20/09/202215:47Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:IDXGInterpace Biosciences Inc
20/09/202215:37Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:IDXGInterpace Biosciences Inc
09/09/202215:29Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:IDXGInterpace Biosciences Inc
01/09/202216:18GlobeNewswire Inc.Interpace Biosciences Announces New Clinical Validation Data; Diagnostic Accuracy Significantly ImprovedNASDAQ:IDXGInterpace Biosciences Inc
31/08/202216:30GlobeNewswire Inc.Interpace Biosciences Completes Sale of Its Pharma Services Business to Flagship Biosciences, Inc.NASDAQ:IDXGInterpace Biosciences Inc
15/08/202215:05GlobeNewswire Inc.Interpace Biosciences Announces Second Quarter 2022 Financial and Business Results and New Clinical Validation Data; Diagnostic Accuracy Significantly ImprovedNASDAQ:IDXGInterpace Biosciences Inc
16/05/202215:15GlobeNewswire Inc.Interpace Biosciences Announces First Quarter 2022 Financial and Business ResultsNASDAQ:IDXGInterpace Biosciences Inc
11/05/202207:30GlobeNewswire Inc.Miroculus to Optimize Automated Next Generation Sequencing Library Preparation with Interpace Diagnostics and Twist BioscienceNASDAQ:IDXGInterpace Biosciences Inc
08/04/202205:15TipRanksAnalysts Offer Insights on Healthcare Companies: Interpace Diagnostics Group (OtherIDXG) and Biogen (BIIB)NASDAQ:IDXGInterpace Biosciences Inc
31/03/202215:15GlobeNewswire Inc.Interpace Biosciences Announces Full Year and Fourth Quarter 2021 Financial and Business ResultsNASDAQ:IDXGInterpace Biosciences Inc
22/02/202208:00GlobeNewswire Inc.Interpace Biosciences Announces Update of Previously Announced CMS Billing Policy Impacting its Thyroid TestsNASDAQ:IDXGInterpace Biosciences Inc
02/02/202215:04Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IDXGInterpace Biosciences Inc
01/02/202209:16Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:IDXGInterpace Biosciences Inc
28/01/202218:35GlobeNewswire Inc.Interpace Biosciences Terminates Rights Offering Announces Change in CMS Medicare Reimbursement of its Thyroid TestsNASDAQ:IDXGInterpace Biosciences Inc
27/01/202215:05GlobeNewswire Inc.Interpace Biosciences Announces Appointment of Vijay Aggarwal, Ph.D. as New DirectorNASDAQ:IDXGInterpace Biosciences Inc
13/01/202205:05Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:IDXGInterpace Biosciences Inc
13/01/202205:05Edgar (US Regulatory)Post-effective Amendment Filed Solely to Add Exhibits to a Registration Statement (pos Ex)NASDAQ:IDXGInterpace Biosciences Inc
12/01/202215:41GlobeNewswire Inc.Interpace Biosciences Announces Commencement of Fully Back-Stopped $30 Million Rights OfferingNASDAQ:IDXGInterpace Biosciences Inc
03/01/202216:07GlobeNewswire Inc.Interpace Biosciences Announces Record Date for Proposed Fully Back-Stopped $30 Million Rights OfferingNASDAQ:IDXGInterpace Biosciences Inc
10/11/202115:05GlobeNewswire Inc.Interpace Biosciences Announces Third Quarter 2021 Financial and Business ResultsNASDAQ:IDXGInterpace Biosciences Inc
02/11/202115:15GlobeNewswire Inc.Interpace Biosciences Announces New $8 Million Term Loan with BroadOak Capital Partners and Repayment of Private Equity LoansNASDAQ:IDXGInterpace Biosciences Inc
28/10/202107:15GlobeNewswire Inc.Interpace Biosciences Announces U.S. PTO Issuance of Patent No. 11,143,657 Titled: Topographic Genotyping for Determining the Diagnosis, Malignant Potential, and Biologic Behavior of Pancreatic Cysts and Related ConditionsNASDAQ:IDXGInterpace Biosciences Inc
21/10/202108:15GlobeNewswire Inc.Interpace Diagnostics Announces US Patent Approval for Patent Application No. 11,118, 231 B2 Titled: microRNAs as Biomarkers for Distinguishing Benign from Malignant Thyroid NeoplasmsNASDAQ:IDXGInterpace Biosciences Inc
 Showing the most relevant articles for your search:NASDAQ:IDXG

Su Consulta Reciente

PM
XAUUSD
Gold vs US Dollar
NYSE
NKE
Nike
NYSE
MCD
McDonalds
AMEX
XLE
Energy Select Sector SPDR
USOTC
BNPQY
BNP Paribas (QX)
NASDAQ
AMZN
Amazon.com
NYSE
DIS
Walt Disney
USOTC
ADDYY
Adidas (QX)
USOTC
DTEGY
Deutsche Telekom (QX)
NYSE
XOM
Exxon Mobil
USI
USTECH100
US Tech 100
SPI
SP500
S&P 500
NYSE
BAC
Bank of America
COIN
ETHUSD
Ethereum
NYSE
KO
Coca Cola
CCOM
OILBRENT
Brent Oil
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados